Cardiac implantable electronic device infections: Who is at greatest risk?
- 1 June 2017
- journal article
- research article
- Published by Elsevier in Heart Rhythm
- Vol. 14 (6) , 839-845
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Pacemaker or Defibrillator Surgery without Interruption of AnticoagulationNew England Journal of Medicine, 2013
- 16-Year Trends in the Infection Burden for Pacemakers and Implantable Cardioverter-Defibrillators in the United StatesJACC, 2011
- Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patientsEuropean Heart Journal, 2011
- Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade ProceduresCirculation, 2010
- Permanent Pacemaker and Implantable Cardioverter Defibrillator Infections: Seven Years of Diagnostic and Therapeutic Experience of a Single CenterClinical Cardiology, 2010
- Update on Cardiovascular Implantable Electronic Device Infections and Their ManagementCirculation, 2010
- Contemporary management of and outcomes from cardiac device related infectionsEP Europace, 2009
- Prevalence and risk factors related to infections of cardiac resynchronization therapy devicesEuropean Heart Journal, 2009
- Efficacy of Antibiotic Prophylaxis Before the Implantation of Pacemakers and Cardioverter-DefibrillatorsCirculation: Arrhythmia and Electrophysiology, 2009
- Risk factors and time delay associated with cardiac device infections: Leiden device registryHeart, 2008